Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Checkpoint Inhibitors in the Treatment of Breast Cancer.

Lyons TG, Dickler MN, Comen EE.

Curr Oncol Rep. 2018 Apr 30;20(7):51. doi: 10.1007/s11912-018-0701-2. Review.

PMID:
29713831
2.

Systemic therapy for esophagogastric cancer: immune checkpoint inhibition.

Lyons TG, Ku GY.

Chin Clin Oncol. 2017 Oct;6(5):53. doi: 10.21037/cco.2017.09.03.

3.

Systemic therapy for esophagogastric cancer: targeted therapies.

Lyons TG, Ku GY.

Chin Clin Oncol. 2017 Oct;6(5):48. doi: 10.21037/cco.2017.07.02.

4.

How can clinical research help our understanding of trastuzumab-related cardiotoxicity?

Lyons TG, Morris PG.

EBioMedicine. 2015 Jul 17;2(8):802-3. doi: 10.1016/j.ebiom.2015.07.021. eCollection 2015 Aug. Review. No abstract available.

5.

Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.

O'Kane GM, Lyons TG, Colleran GC, Ahmad MW, Alken S, Kavanagh EC, Fitzpatrick D, Murray B, Kelly CM.

Oncol Res Treat. 2014;37(12):757-60. doi: 10.1159/000368316. Epub 2014 Oct 30.

PMID:
25531722
6.

Efficacy and safety of vismodegib : a new therapeutic agent in the treatment of basal cell carcinoma.

Lyons TG, O'Kane GM, Kelly CM.

Expert Opin Drug Saf. 2014 Aug;13(8):1125-32. doi: 10.1517/14740338.2014.939952. Review.

PMID:
25033383

Supplemental Content

Loading ...
Support Center